The International Market Analysis Research and Consulting Group (IMARC Group) has been keeping the top position in terms of provision consultancy services on management strategy and market for above 5 years.
IMARC Group serves customers from diverse industry areas in various regions of the globe by identifying their premium-value biz opps, dealing with their most burning issues, and converting their businesses. The company bears its clients a hand in improving decision-making and strategy-planning processes as well as in moving their business to a higher level.
The reports published by IMARC offer precise information on a slew of industries such as pharmaceutical, high-technology, advanced materials, food and beverage, biotechnology, nanotechnology, tourism and travel and a far more. The reports include detailed market analyses, overviews and forecasts, reviews of the economic and technological developments, profiles of the dominant companies, market/product assessments, etc. IMARC’s research approach unites deep insight into the market dynamics together with strong cooperation with each level of the client organization.
Publications found:
9,055
Sort by:
Palmoplantar Pustulosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major palmoplantar pustulosis markets reached a value of US$ 532.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,064.5 Million by 2034, exhibiting a growth rate (C...
May 2024
128 pages
Pancreatic Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major pancreatic cancer markets reached a value of US$ 2,114.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8,005.8 Million by 2034, exhibiting a growth rate (CAGR)...
May 2024
129 pages
Peripheral T-cell Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major peripheral T-cell lymphoma markets reached a value of US$ 608.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,003.2 Million by 2034, exhibiting a growth rate...
May 2024
128 pages
Pertussis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major pertussis markets reached a value of US$ 3,704.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 6,709.2 Million by 2034, exhibiting a growth rate (CAGR) of 5.55...
May 2024
140 pages
Phenylketonuria Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major phenylketonuria markets reached a value of US$ 956.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4,734.0 Million by 2034, exhibiting a growth rate (CAGR) of...
May 2024
130 pages
Polymyalgia Rheumatica Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major polymyalgia rheumatica markets reached a value of US$ 3,287.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 12,677.8 Million by 2034, exhibiting a growth rate...
May 2024
131 pages
Postoperative Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major postoperative pain markets reached a value of US$ 2,615.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5,456.0 Million by 2034, exhibiting a growth rate (CAGR...
May 2024
128 pages
